Malin fund is weighing up one more acquisition

Malin, the €440 million Irish biotech and healthcare fund, said it is considering one more acquisition before it looks to capitalise on the value of its existing portfolio of companies.

Malin said its buying spree was now largely complete, but it said one more “small and simple” investment could be on the cards, although a target had not been identified.

Malin raised €330 million, before expenses, from investors in March and a further ...